PCA SKIN INTENSIVE CLARITY TREATMENT- salicylic acid gel 
CP Skin Health Group, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

PCA SKIN Intensive Clarity Treatment

Active Ingredient

Salicylic Acid (2.0%)     

Purpose

Acne Treatment

Uses

For the treatment of acne.  Helps keep skin clear of new acne pimples, blackheads and/or whiteheads.

Warnings

For external use only

When using this product

Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time.  If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

  If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive Ingredients

Water, Glycerin, PEG-12 Glyceryl Dimyristate, Cyclopentasiloxane, Isododecane, Niacinamide, Butylene Glycol, Dimethicone, Ammonium Acryloyldimethyltaurate/VP Copolymer, Cetearyl Alcohol, Isoamyl Laurate, Glyceryl Stearate, PEG-100 Stearate, Sodium Polyacrylate,
Polysilicone-11, Bakuchiol, Caprylic/Capric Triglyceride, Maltodextrin, Phenoxyethanol, Coco-Caprylate/Caprate, Hexyl Resorcinol, Ethylhexyl Stearate, Retinol, Ethyl Linoleate, Polysorbate 20, Hexylresorcinol, Dipotassium Glycrrhizinate, Caprylyl Glycol, Trideceth-6, Xanthan Gum, Chlorphenesin, Pentylene Glycol, Isoamyl Cocoate, Syringa Vulgaris (Lilac) Leaf Cell Culture Extract, Sodium Citrate, Disodium EDTA, Decyl Glucoside, Myristoyl Nonapeptide-3, Citric Acid

ICTuc

PCA SKIN INTENSIVE CLARITY TREATMENT 
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68726-359
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
PEG-12 GLYCERYL DIMYRISTATE (UNII: VS4W16AQ3X)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
ISODODECANE (UNII: A8289P68Y2)  
NIACINAMIDE (UNII: 25X51I8RD4)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
ISOAMYL LAURATE (UNII: M1SLX00M3M)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
PEG-100 STEARATE (UNII: YD01N1999R)  
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)  
SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L)  
BAKUCHIOL (UNII: OT12HJU3AR)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
COCO-CAPRYLATE (UNII: 4828G836N6)  
RETINOL (UNII: G2SH0XKK91)  
ETHYLHEXYL STEARATE (UNII: EG3PA2K3K5)  
ETHYL LINOLEATE (UNII: MJ2YTT4J8M)  
HEXYLRESORCINOL (UNII: R9QTB5E82N)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
XANTHAN GUM (UNII: TTV12P4NEE)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
TRIDECETH-6 (UNII: 3T5PCR2H0C)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
ISOAMYL COCOATE (UNII: 14OG46E98E)  
SYRINGA VULGARIS FLOWER (UNII: 9V5O040S3W)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
DECYL GLUCOSIDE (UNII: Z17H97EA6Y)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
MYRISTOYL PENTAPEPTIDE-4 (UNII: PMA59A699X)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68726-359-021 in 1 CARTON06/08/2018
1NDC:68726-359-0129.5 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:68726-359-032 g in 1 TUBE; Type 0: Not a Combination Product06/08/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM00606/08/2018
Labeler - CP Skin Health Group, Inc. (611921669)

Revised: 11/2022
Document Id: ec94d68f-be6b-90bf-e053-2a95a90a597c
Set id: 7bd6edc0-941e-492d-8b3c-4e8b3425f929
Version: 7
Effective Time: 20221103
 
CP Skin Health Group, Inc.